Exhibit 99.1 Insulet Reports Full Year 2023 Revenue Increase of 30% (30% constant currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% constant currency) Represents 8th Consecutive Year of 20% or More Constant Currency Revenue Growth ACTON, Mass. - February 22, 2024 - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months and full y ...